Read More Pharma Industry News Sobi and Apellis Pharmaceuticals report promising results for pegcetacoplan in phase 2 NOBLE study Sobi and Apellis Pharmaceuticals, Inc. have announced encouraging one-year outcomes from the phase 2 NOBLE study, investigating the… byPallavi MadhirajuMay 26, 2024